Literature DB >> 25010388

HMGB1 in health and disease.

Rui Kang1, Ruochan Chen2, Qiuhong Zhang2, Wen Hou2, Sha Wu2, Lizhi Cao3, Jin Huang4, Yan Yu3, Xue-Gong Fan5, Zhengwen Yan6, Xiaofang Sun7, Haichao Wang8, Qingde Wang2, Allan Tsung2, Timothy R Billiar2, Herbert J Zeh2, Michael T Lotze2, Daolin Tang9.   

Abstract

Complex genetic and physiological variations as well as environmental factors that drive emergence of chromosomal instability, development of unscheduled cell death, skewed differentiation, and altered metabolism are central to the pathogenesis of human diseases and disorders. Understanding the molecular bases for these processes is important for the development of new diagnostic biomarkers, and for identifying new therapeutic targets. In 1973, a group of non-histone nuclear proteins with high electrophoretic mobility was discovered and termed high-mobility group (HMG) proteins. The HMG proteins include three superfamilies termed HMGB, HMGN, and HMGA. High-mobility group box 1 (HMGB1), the most abundant and well-studied HMG protein, senses and coordinates the cellular stress response and plays a critical role not only inside of the cell as a DNA chaperone, chromosome guardian, autophagy sustainer, and protector from apoptotic cell death, but also outside the cell as the prototypic damage associated molecular pattern molecule (DAMP). This DAMP, in conjunction with other factors, thus has cytokine, chemokine, and growth factor activity, orchestrating the inflammatory and immune response. All of these characteristics make HMGB1 a critical molecular target in multiple human diseases including infectious diseases, ischemia, immune disorders, neurodegenerative diseases, metabolic disorders, and cancer. Indeed, a number of emergent strategies have been used to inhibit HMGB1 expression, release, and activity in vitro and in vivo. These include antibodies, peptide inhibitors, RNAi, anti-coagulants, endogenous hormones, various chemical compounds, HMGB1-receptor and signaling pathway inhibition, artificial DNAs, physical strategies including vagus nerve stimulation and other surgical approaches. Future work further investigating the details of HMGB1 localization, structure, post-translational modification, and identification of additional partners will undoubtedly uncover additional secrets regarding HMGB1's multiple functions.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biology; DAMP; Disease; HMGB1

Mesh:

Substances:

Year:  2014        PMID: 25010388      PMCID: PMC4254084          DOI: 10.1016/j.mam.2014.05.001

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  1849 in total

1.  Biochemical observation of the rapid mobility of nuclear HMGB1.

Authors:  Nelly Sapojnikova; Joseph Maman; Fiona A Myers; Alan W Thorne; Vladimir I Vorobyev; Colyn Crane-Robinson
Journal:  Biochim Biophys Acta       Date:  2005-03-17

2.  Mitochondrial localization of non-histone protein HMGB1 during human endothelial cell-Toxoplasma gondii infection.

Authors:  Ana Carolina Stumbo; Erika Cortez; Carlos Alberto Rodrigues; Maria das Graças M O Henriques; Luís Cristóvão Porto; Helene S Barbosa; Laís Carvalho
Journal:  Cell Biol Int       Date:  2007-09-07       Impact factor: 3.612

3.  Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients.

Authors:  Tetsuya Watanabe; Kazuhisa Asai; Hiroki Fujimoto; Hidenori Tanaka; Hiroshi Kanazawa; Kazuto Hirata
Journal:  Respir Med       Date:  2010-10-30       Impact factor: 3.415

Review 4.  Linker histones versus HMG1/2: a struggle for dominance?

Authors:  J Zlatanova; K van Holde
Journal:  Bioessays       Date:  1998-07       Impact factor: 4.345

5.  Alarmin HMGB1 is released in the small intestine of gnotobiotic piglets infected with enteric pathogens and its level in plasma reflects severity of sepsis.

Authors:  Alla Splichalova; Igor Splichal; Petra Chmelarova; Ilja Trebichavsky
Journal:  J Clin Immunol       Date:  2011-01-12       Impact factor: 8.317

6.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

7.  CRM1-mediated nuclear export: to the pore and beyond.

Authors:  Saskia Hutten; Ralph H Kehlenbach
Journal:  Trends Cell Biol       Date:  2007-02-20       Impact factor: 20.808

8.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

Authors:  Beatriz Rendon-Mitchell; Mahendar Ochani; Jianhua Li; Jialian Han; Hong Wang; Huan Yang; Seenu Susarla; Christopher Czura; Robert A Mitchell; Guoqian Chen; Andrew E Sama; Kevin J Tracey; Haichao Wang
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Ethyl pyruvate administration inhibits hepatic tumor growth.

Authors:  Xiaoyan Liang; Antonio Romo de Vivar Chavez; Nicole E Schapiro; Patricia Loughran; Stephen H Thorne; Andrew A Amoscato; Herbert J Zeh; Donna Beer-Stolz; Michael T Lotze; Michael E de Vera
Journal:  J Leukoc Biol       Date:  2009-09       Impact factor: 4.962

10.  [Expression of high mobility group box chromosomal protein 1 in mice with lupus nephritis].

Authors:  Jian-Guang Zhou; Jing-Yin Dong; Li-Huang Zhang; Jing Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2011-03
View more
  311 in total

Review 1.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

2.  HMGB1-Neutralizing IgM Antibody Is a Normal Component of Blood Plasma.

Authors:  Yajun Geng; Gnanasekar Munirathinam; Sunil Palani; Joseph E Ross; Bin Wang; Aoshuang Chen; Guoxing Zheng
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

3.  PCV2 Induces Reactive Oxygen Species To Promote Nucleocytoplasmic Translocation of the Viral DNA Binding Protein HMGB1 To Enhance Its Replication.

Authors:  Renjie Sun; Siqi Sun; Yikai Zhang; Yingshan Zhou; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 4.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

5.  Paeonol Reduces the Nucleocytoplasmic Transportation of HMGB1 by Upregulating HDAC3 in LPS-Induced RAW264.7 Cells.

Authors:  Qin Xu; Xia Liu; Liyan Mei; Quan Wen; Jing Chen; Jifei Miao; Hang Lei; Huina Huang; Dongfeng Chen; Shaohui Du; Aijun Liu; Saixia Zhang; Jianhong Zhou; Rudong Deng; Yiwei Li; Chun Li; Hui Li
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Effect of in vivo post-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study.

Authors:  Wenping Lyu Lv; Fabio Arnesano; Paolo Carloni; Giovanni Natile; Giulia Rossetti
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

7.  Hepatocyte-specific Hmgb1 Deletion.

Authors:  Xiaofang Sun; Daolin Tang
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

8.  A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis.

Authors:  Rui Kang; Ling Zeng; Yangchun Xie; Zhengwen Yan; Borong Zhou; Lizhi Cao; Daniel J Klionsky; Kevin J Tracey; Jianhua Li; Haichao Wang; Timothy R Billiar; Jianxin Jiang; Daolin Tang
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

9.  High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes.

Authors:  Margaret A Baumbusch; Catalin S Buhimschi; Emily A Oliver; Guomao Zhao; Stephen Thung; Kara Rood; Irina A Buhimschi
Journal:  Cytokine       Date:  2016-03-05       Impact factor: 3.861

10.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.